The right Timing, right combination, right sequence, and right delivery for Cancer immunotherapy
出版年份 2021 全文链接
标题
The right Timing, right combination, right sequence, and right delivery for Cancer immunotherapy
作者
关键词
Cancer, Combination, Immunotherapy, Sequence, Timing
出版物
JOURNAL OF CONTROLLED RELEASE
Volume -, Issue -, Pages -
出版商
Elsevier BV
发表日期
2021-01-11
DOI
10.1016/j.jconrel.2021.01.009
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Inhibition of Immunosuppressive Tumors by Polymer‐Assisted Inductions of Immunogenic Cell Death and Multivalent PD‐L1 Crosslinking
- (2020) Lian Li et al. ADVANCED FUNCTIONAL MATERIALS
- A review of cancer immunotherapy toxicity
- (2020) Lucy Boyce Kennedy et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Nanoparticle Conjugation Stabilizes and Multimerizes β-Hairpin Peptides To Effectively Target PD-1/PD-L1 β-Sheet-Rich Interfaces
- (2020) Woo-jin Jeong et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- Radiotherapy‐immunotherapy combinations: perspectives and challenges
- (2020) Michele Mondini et al. Molecular Oncology
- Harnessing cancer immunotherapy during the unexploited immediate perioperative period
- (2020) Pini Matzner et al. Nature Reviews Clinical Oncology
- Pembrolizumab for Early Triple-Negative Breast Cancer
- (2020) Peter Schmid et al. NEW ENGLAND JOURNAL OF MEDICINE
- Neoadjuvant checkpoint blockade for cancer immunotherapy
- (2020) Suzanne L. Topalian et al. SCIENCE
- Resistance Mechanism of PD-1/PD-L1 Blockade in the Cancer-Immunity Cycle
- (2020) Yuan Zhuang et al. OncoTargets and Therapy
- Trial watch: chemotherapy-induced immunogenic cell death in immuno-oncology
- (2020) Isaure Vanmeerbeek et al. OncoImmunology
- A Prospective, Phase 1 Trial of Nivolumab, Ipilimumab, and Radiotherapy in Patients with Advanced Melanoma
- (2020) Michael A. Postow et al. CLINICAL CANCER RESEARCH
- A tumor-intrinsic PD-L1/NLRP3 inflammasome signaling pathway drives resistance to anti–PD-1 immunotherapy
- (2020) Balamayoora Theivanthiran et al. JOURNAL OF CLINICAL INVESTIGATION
- Xenogenization of tumor cells by fusogenic exosomes in tumor microenvironment ignites and propagates antitumor immunity
- (2020) Gi Beom Kim et al. Science Advances
- Emerging Prospects of Exosomes for Cancer Treatment: From Conventional Therapy to Immunotherapy
- (2020) Gi‐Hoon Nam et al. ADVANCED MATERIALS
- Functionalized exosome harboring bioactive molecules for cancer therapy
- (2020) Yoon Kyoung Kim et al. CANCER LETTERS
- Combination Immunotherapy Using Oncolytic Virus for the Treatment of Advanced Solid Tumors
- (2020) Chang-Myung Oh et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Human intratumoral therapy: Linking drug properties and tumor transport of drugs in clinical trials
- (2020) Aric Huang et al. JOURNAL OF CONTROLLED RELEASE
- Anti-angiogenesis: Opening a new window for immunotherapy
- (2020) Feifei Guo et al. LIFE SCIENCES
- Blockade of immune checkpoints in lymph nodes through locoregional delivery augments cancer immunotherapy
- (2020) David M. Francis et al. Science Translational Medicine
- Vaccination into the Dermal Compartment: Techniques, Challenges, and Prospects
- (2020) Johanna Hettinga et al. Vaccines
- Improving safety of cancer immunotherapy via delivery technology
- (2020) Doudou Hu et al. BIOMATERIALS
- Progress and perspective of microneedle system for anti-cancer drug delivery
- (2020) Dongdong Li et al. BIOMATERIALS
- Phenylboronic-acid-based nanocomplex as a feasible delivery platform of immune checkpoint inhibitor for potent cancer immunotherapy
- (2020) Junha Lim et al. JOURNAL OF CONTROLLED RELEASE
- Enhancing anti-tumor response by combining immune checkpoint inhibitors with chemotherapy in solid tumors
- (2019) K M Heinhuis et al. ANNALS OF ONCOLOGY
- Tumor mutational load predicts survival after immunotherapy across multiple cancer types
- (2019) Robert M. Samstein et al. NATURE GENETICS
- Approaches to treat immune hot, altered and cold tumours with combination immunotherapies
- (2019) Jérôme Galon et al. NATURE REVIEWS DRUG DISCOVERY
- Delivery technologies for cancer immunotherapy
- (2019) Rachel S. Riley et al. NATURE REVIEWS DRUG DISCOVERY
- Timing of neoadjuvant immunotherapy in relation to surgery is crucial for outcome
- (2019) Jing Liu et al. OncoImmunology
- Regulatory T cells in cancer immunosuppression — implications for anticancer therapy
- (2019) Yosuke Togashi et al. Nature Reviews Clinical Oncology
- Neoadjuvant anti-PD-1 immunotherapy promotes a survival benefit with intratumoral and systemic immune responses in recurrent glioblastoma
- (2019) Timothy F. Cloughesy et al. NATURE MEDICINE
- Subsets of exhausted CD8+ T cells differentially mediate tumor control and respond to checkpoint blockade
- (2019) Brian C. Miller et al. NATURE IMMUNOLOGY
- IDO1 inhibition potentiates vaccine-induced immunity against pancreatic adenocarcinoma
- (2019) Alex B. Blair et al. JOURNAL OF CLINICAL INVESTIGATION
- Treg programming and therapeutic reprogramming in cancer
- (2019) Mariela A. Moreno Ayala et al. IMMUNOLOGY
- Clonal Deletion of Tumor-Specific T Cells by Interferon-γ Confers Therapeutic Resistance to Combination Immune Checkpoint Blockade
- (2019) Chien-Chun Steven Pai et al. IMMUNITY
- Choosing wisely first line immunotherapy in non-small cell lung cancer (NSCLC): What to add and what to leave out
- (2019) C. Proto et al. CANCER TREATMENT REVIEWS
- Intrinsic cancer vaccination
- (2019) Yoosoo Yang et al. ADVANCED DRUG DELIVERY REVIEWS
- Acquired generalized lipodystrophy under immune checkpoint inhibition
- (2019) N. Haddad et al. BRITISH JOURNAL OF DERMATOLOGY
- The promise of neoadjuvant immunotherapy and surgery for cancer treatment
- (2019) Jake S O'Donnell et al. CLINICAL CANCER RESEARCH
- The role of PD-1/PD-L1 axis and macrophage in the progression and treatment of cancer
- (2019) Jiajing Cai et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- Immune checkpoint inhibitors, alone or in combination with chemotherapy, as first-line treatment for advanced non-small cell lung cancer. A systematic review and network meta-analysis
- (2019) Urania Dafni et al. LUNG CANCER
- Synergistic effect of immune checkpoint blockade and anti-angiogenesis in cancer treatment
- (2019) Ming Yi et al. Molecular Cancer
- Assessment of Subcutaneous vs Intravenous Administration of Anti–PD-1 Antibody PF-06801591 in Patients With Advanced Solid Tumors
- (2019) Melissa L. Johnson et al. JAMA Oncology
- Remodeling the Tumor Microenvironment Sensitizes Breast Tumors to Anti- Programmed Death-Ligand 1 Immunotherapy
- (2019) Renee Clift et al. CANCER RESEARCH
- Macrophages and Metabolism in the Tumor Microenvironment
- (2019) Ilio Vitale et al. Cell Metabolism
- Building on the anti-PD1/PD-L1 Backbone: Combination Immunotherapy for Cancer
- (2019) Alvaro H Ingles Garces et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- The local immune landscape determines tumor PD-L1 heterogeneity and sensitivity to therapy
- (2019) Yuan Wei et al. JOURNAL OF CLINICAL INVESTIGATION
- PD-1 blockade in subprimed CD8 cells induces dysfunctional PD-1+CD38hi cells and anti-PD-1 resistance
- (2019) Vivek Verma et al. NATURE IMMUNOLOGY
- Acquired resistance to cancer immunotherapy: Role of tumor-mediated immunosuppression
- (2019) Reem Saleh et al. SEMINARS IN CANCER BIOLOGY
- Crizotinib-induced immunogenic cell death in non-small cell lung cancer
- (2019) Peng Liu et al. Nature Communications
- Optimal Timing and Sequence of Immunotherapy When Combined with Stereotactic Radiosurgery in the Treatment of Brain Metastases
- (2019) Mahmoud ElJalby et al. World Neurosurgery
- The multifaceted nature of diabetes mellitus induced by checkpoint inhibitors
- (2019) Lucien Marchand et al. ACTA DIABETOLOGICA
- Combining epigenetic drugs with other therapies for solid tumours — past lessons and future promise
- (2019) Daphné Morel et al. Nature Reviews Clinical Oncology
- A poly-neoantigen DNA vaccine synergizes with PD-1 blockade to induce T cell-mediated tumor control
- (2019) Elena Tondini et al. OncoImmunology
- Small molecule immunomodulation: the tumor microenvironment and overcoming immune escape
- (2019) Arsen Osipov et al. Journal for ImmunoTherapy of Cancer
- Degradation of tumour stromal hyaluronan by small extracellular vesicle-PH20 stimulates CD103+ dendritic cells and in combination with PD-L1 blockade boosts anti-tumour immunity
- (2019) Yeonsun Hong et al. Journal of Extracellular Vesicles
- Built‐In Active Microneedle Patch with Enhanced Autonomous Drug Delivery
- (2019) Miguel Angel Lopez‐Ramirez et al. ADVANCED MATERIALS
- Neoadjuvant cisplatin and paclitaxel modulate tumor-infiltrating T cells in patients with cervical cancer
- (2019) A. Marijne Heeren et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- The emerging use of immune checkpoint blockade in the adjuvant setting for solid tumors: a review
- (2019) Elissar Moujaess et al. Immunotherapy
- Durvalumab plus platinum–etoposide versus platinum–etoposide in first-line treatment of extensive-stage small-cell lung cancer (CASPIAN): a randomised, controlled, open-label, phase 3 trial
- (2019) Luis Paz-Ares et al. LANCET
- Oncolysis without viruses — inducing systemic anticancer immune responses with local therapies
- (2019) Oliver Kepp et al. Nature Reviews Clinical Oncology
- Intratumoral Immunotherapy—Update 2019
- (2019) Omid Hamid et al. ONCOLOGIST
- Antigen presentation and tumor immunogenicity in cancer immunotherapy response prediction
- (2019) Shixiang Wang et al. eLife
- Intratumoral injection of the seasonal flu shot converts immunologically cold tumors to hot and serves as an immunotherapy for cancer
- (2019) Jenna H. Newman et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Nanocage-Therapeutics Prevailing Phagocytosis and Immunogenic Cell Death Awakens Immunity against Cancer
- (2018) Eun Jung Lee et al. ADVANCED MATERIALS
- Immune Checkpoint Inhibitor Nivolumab and Radiotherapy in Pretreated Lung Cancer Patients
- (2018) Francesco Fiorica et al. AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS
- Designed trimer-mimetic TNF superfamily ligands on self-assembling nanocages
- (2018) Minwoo Kih et al. BIOMATERIALS
- T Cell Dysfunction in Cancer
- (2018) Daniela S. Thommen et al. CANCER CELL
- Radiation therapy and immunotherapy: what is the optimal timing or sequencing?
- (2018) Maureen L Aliru et al. Immunotherapy
- Dose-limiting Urinary Toxicity With Pembrolizumab Combined With Weekly Hypofractionated Radiation Therapy in Bladder Cancer
- (2018) Alison Claire Tree et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Understanding the tumor immune microenvironment (TIME) for effective therapy
- (2018) Mikhail Binnewies et al. NATURE MEDICINE
- Mechanisms of BCG immunotherapy and its outlook for bladder cancer
- (2018) Caroline Pettenati et al. Nature Reviews Urology
- Neoadjuvant PD-1 Blockade in Resectable Lung Cancer
- (2018) Patrick M. Forde et al. NEW ENGLAND JOURNAL OF MEDICINE
- Macrophages impede CD8 T cells from reaching tumor cells and limit the efficacy of anti–PD-1 treatment
- (2018) Elisa Peranzoni et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Cancer immunotherapy using checkpoint blockade
- (2018) Antoni Ribas et al. SCIENCE
- Combined Rho-kinase inhibition and immunogenic cell death triggers and propagates immunity against cancer
- (2018) Gi-Hoon Nam et al. Nature Communications
- CD38-mediated immunosuppression as a mechanism of tumor cell escape from PD-1/PD-L1 blockade
- (2018) Limo Chen et al. Cancer Discovery
- Myeloid-Derived Suppressor Cells Hinder the Anti-Cancer Activity of Immune Checkpoint Inhibitors
- (2018) Rebekka Weber et al. Frontiers in Immunology
- PD-1/PD-L1 pathway: an adaptive immune resistance mechanism to immunogenic chemotherapy in colorectal cancer
- (2018) Magalie Dosset et al. OncoImmunology
- Increase in PD-L1 expression after pre-operative radiotherapy for soft tissue sarcoma
- (2018) Kirtesh R. Patel et al. OncoImmunology
- Effect of neoadjuvant chemotherapy on the immune microenvironment in non–small cell lung carcinomas as determined by multiplex immunofluorescence and image analysis approaches
- (2018) Edwin R. Parra et al. Journal for ImmunoTherapy of Cancer
- Phase II study of neoadjuvant checkpoint blockade in patients with surgically resectable undifferentiated pleomorphic sarcoma and dedifferentiated liposarcoma
- (2018) Emily Z. Keung et al. BMC CANCER
- Treg Destabilization and Reprogramming: Implications for Cancer Immunotherapy
- (2018) David H. Munn et al. CANCER RESEARCH
- Nanotechnology-mediated immunochemotherapy combined with docetaxel and PD-L1 antibody increase therapeutic effects and decrease systemic toxicity
- (2018) Zili Gu et al. JOURNAL OF CONTROLLED RELEASE
- The hallmarks of successful anticancer immunotherapy
- (2018) Lorenzo Galluzzi et al. Science Translational Medicine
- Topography of cancer-associated immune cells in human solid tumors
- (2018) Jakob Nikolas Kather et al. eLife
- Apoptosis of tumor-infiltrating T lymphocytes: a new immune checkpoint mechanism
- (2018) Jingjing Zhu et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Treatment-Induced Tumor Cell Apoptosis and Secondary Necrosis Drive Tumor Progression in the Residual Tumor Microenvironment through MerTK and IDO1
- (2018) Thomas A. Werfel et al. CANCER RESEARCH
- Defining T Cell States Associated with Response to Checkpoint Immunotherapy in Melanoma
- (2018) Moshe Sade-Feldman et al. CELL
- The application of nanotechnology in immune checkpoint blockade for cancer treatment
- (2018) Huan Deng et al. JOURNAL OF CONTROLLED RELEASE
- Impact of cytotoxic chemotherapy on PD-L1 expression in patients with non–small cell lung cancer negative for EGFR mutation and ALK fusion
- (2018) Hitomi Sakai et al. LUNG CANCER
- Neoadjuvant immune checkpoint blockade in high-risk resectable melanoma
- (2018) Rodabe N. Amaria et al. NATURE MEDICINE
- Long-term survival of patients after ipilimumab and hypofractionated brain radiotherapy for brain metastases of malignant melanoma: sequence matters
- (2018) Heinz Schmidberger et al. STRAHLENTHERAPIE UND ONKOLOGIE
- Immune checkpoint inhibitors in cancer therapy: a focus on T-regulatory cells
- (2017) Varun Sasidharan Nair et al. IMMUNOLOGY AND CELL BIOLOGY
- Ferritin nanocage with intrinsically disordered proteins and affibody: A platform for tumor targeting with extended pharmacokinetics
- (2017) Na Kyeong Lee et al. JOURNAL OF CONTROLLED RELEASE
- Arsenic trioxide decreases the amount and inhibits the function of regulatory T cells, which may contribute to its efficacy in the treatment of acute promyelocytic leukemia
- (2017) Wen Xu et al. LEUKEMIA & LYMPHOMA
- Elements of cancer immunity and the cancer–immune set point
- (2017) Daniel S. Chen et al. NATURE
- The immune contexture in cancer prognosis and treatment
- (2017) Wolf H. Fridman et al. Nature Reviews Clinical Oncology
- Tumor Mutational Burden and Response Rate to PD-1 Inhibition
- (2017) Mark Yarchoan et al. NEW ENGLAND JOURNAL OF MEDICINE
- Rationale for neoadjuvant immunotherapy in head and neck squamous cell carcinoma
- (2017) Glenn J. Hanna et al. ORAL ONCOLOGY
- Resistance to cancer immunotherapy mediated by apoptosis of tumor-infiltrating lymphocytes
- (2017) Jingjing Zhu et al. Nature Communications
- Intratumoral STING Activation with T-cell Checkpoint Modulation Generates Systemic Antitumor Immunity
- (2017) Casey R. Ager et al. Cancer Immunology Research
- Bioengineered protein-based nanocage for drug delivery
- (2016) Eun Jung Lee et al. ADVANCED DRUG DELIVERY REVIEWS
- Regulatory T cells in cancer immunotherapy
- (2016) Atsushi Tanaka et al. CELL RESEARCH
- Reversing T-cell Dysfunction and Exhaustion in Cancer
- (2016) H. M. Zarour CLINICAL CANCER RESEARCH
- CD137 Stimulation Enhances Cetuximab-Induced Natural Killer: Dendritic Cell Priming of Antitumor T-Cell Immunity in Patients with Head and Neck Cancer
- (2016) Raghvendra M. Srivastava et al. CLINICAL CANCER RESEARCH
- The Where, the When, and the How of Immune Monitoring for Cancer Immunotherapies in the Era of Checkpoint Inhibition
- (2016) P. S. Hegde et al. CLINICAL CANCER RESEARCH
- Microsatellite Instability as a Biomarker for PD-1 Blockade
- (2016) J. C. Dudley et al. CLINICAL CANCER RESEARCH
- Concurrent irradiation with the anti-programmed cell death ligand-1 immune checkpoint blocker durvalumab: Single centre subset analysis from a phase 1/2 trial
- (2016) Antonin Levy et al. EUROPEAN JOURNAL OF CANCER
- Local checkpoint inhibition of CTLA-4 as a monotherapy or in combination with anti-PD1 prevents the growth of murine bladder cancer
- (2016) Luuk van Hooren et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Immunogenic Chemotherapy Sensitizes Tumors to Checkpoint Blockade Therapy
- (2016) Christina Pfirschke et al. IMMUNITY
- Predictive biomarkers for checkpoint inhibitor-based immunotherapy
- (2016) Geoffrey T Gibney et al. LANCET ONCOLOGY
- Clonal neoantigens elicit T cell immunoreactivity and sensitivity to immune checkpoint blockade
- (2016) N. McGranahan et al. SCIENCE
- Improved Efficacy of Neoadjuvant Compared to Adjuvant Immunotherapy to Eradicate Metastatic Disease
- (2016) J. Liu et al. Cancer Discovery
- Analysis of Immune Signatures in Longitudinal Tumor Samples Yields Insight into Biomarkers of Response and Mechanisms of Resistance to Immune Checkpoint Blockade
- (2016) P.-L. Chen et al. Cancer Discovery
- Optimizing Timing of Immunotherapy Improves Control of Tumors by Hypofractionated Radiation Therapy
- (2016) Kristina H. Young et al. PLoS One
- Cancer Neoantigens and Applications for Immunotherapy
- (2015) A. Desrichard et al. CLINICAL CANCER RESEARCH
- PD-L1 Expression as a Predictive Biomarker in Cancer Immunotherapy
- (2015) S. P. Patel et al. MOLECULAR CANCER THERAPEUTICS
- Neoantigens in cancer immunotherapy
- (2015) T. N. Schumacher et al. SCIENCE
- Oncology Meets Immunology: The Cancer-Immunity Cycle
- (2013) Daniel S. Chen et al. IMMUNITY
- Methyl Gallate Exhibits Potent Antitumor Activities by Inhibiting Tumor Infiltration of CD4+CD25+ Regulatory T Cells
- (2010) H. Lee et al. JOURNAL OF IMMUNOLOGY
- Local Release of Highly Loaded Antibodies from Functionalized Nanoporous Support for Cancer Immunotherapy
- (2010) Chenghong Lei et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started